Diseases, Conditions, Syndromes

Immune memory less durable after severe COVID-19, study suggests

Infection-fighting B cells retain better memory of the coronavirus spike protein in University Hospital patients who recover from less-severe cases of COVID-19 than in those recovering from severe COVID-19, a new study suggests. ...

Immunology

Vaccine efficacy is a 'gut reaction'

Varying immune response to vaccinations could be countered with microbiota-targeted interventions helping infants, older people and others to take full advantage of the benefits of effective vaccines, Australian and US experts ...

Diseases, Conditions, Syndromes

Reducing unnecessary medication for hepatitis B patients

Not all chronic hepatitis B (HBV) patients require lifelong treatment; but the risks of blindly withdrawing treatment can be severe. However, there's little consensus on which patients can be safely discontinued from treatment, ...

Medical research

B-cell discovery suggests why women suffer more autoimmune disease

Researchers at National Jewish Health have discovered a type of cell that may contribute to autoimmune disease and suggests why diseases such as lupus, multiple sclerosis and rheumatoid arthritis strike women more frequently ...

Vaccination

Current vaccines teach T cells to fight Omicron: study

Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2. ...

Medications

First lupus breakthrough in 50 years

(Medical Xpress) -- A Monash researcher has played a crucial role in the first major lupus treatment breakthrough for over 50 years.

page 8 from 40